Bioactivity and Control Efficacy of Benzovindiflupyr Against Athelia rolfsii in China
Athelia rolfsii is a devastating soilborne pathogen that causes stem rot of peanut and severely restricts peanut production. The new generation of succinate dehydrogenase inhibitor (SDHI) fungicide benzovindiflupyr has been registered in the United States and Brazil for managing multiple plant disea...
| Veröffentlicht in: | Plant disease. - 1997. - 107(2023), 8 vom: 23. Aug., Seite 2359-2364 |
|---|---|
| 1. Verfasser: | |
| Weitere Verfasser: | , , , , , , , |
| Format: | Online-Aufsatz |
| Sprache: | English |
| Veröffentlicht: |
2023
|
| Zugriff auf das übergeordnete Werk: | Plant disease |
| Schlagworte: | Journal Article Athelia rolfsii baseline sensitivity benzovindiflupyr efficacy peanut Fungicides, Industrial S98L0WK1W7 |
| Zusammenfassung: | Athelia rolfsii is a devastating soilborne pathogen that causes stem rot of peanut and severely restricts peanut production. The new generation of succinate dehydrogenase inhibitor (SDHI) fungicide benzovindiflupyr has been registered in the United States and Brazil for managing multiple plant diseases. However, it is not registered in China to control peanut stem rot. In this study, 246 isolates from major peanut production areas in Shandong, Henan, and Hebei Provinces of China were used to determine the baseline sensitivity of A. rolfsii to benzovindiflupyr. The frequency of EC50 values of benzovindiflupyr was unimodally distributed with an average EC50 of 0.12 ± 0.05 mg/liter and a range of 0.01 to 0.57 mg/liter. Benzovindiflupyr can also strongly inhibit the germination of sclerotia, with an average EC50 of 2.38 ± 1.04 mg/liter (n = 23). In addition, benzovindiflupyr exhibited great in vivo efficacy against A. rolfsii; the protective or curative efficacy (89.87%, 20.39%) of benzovindiflupyr at a concentration of 50 mg/liter was equivalent to that of the control fungicide thifluzamide at 100 mg/liter (86.39%, 16.21%). At the same concentration (e.g., 100 mg/liter), the protective efficacy (93.99%) of benzovindiflupyr was more than twice as high as the curative efficacy (45.07%). A positive correlation existed between benzovindiflupyr and isopyrazam or mefentrifluconazole, which possibly resulted from similar chemical structures or damage to the cell membrane. Our findings provide valuable information for the application of benzovindiflupyr, and the established baseline sensitivity could facilitate the monitoring and assessment of benzovindiflupyr resistance risk |
|---|---|
| Beschreibung: | Date Completed 31.08.2023 Date Revised 31.08.2023 published: Print-Electronic Citation Status MEDLINE |
| ISSN: | 0191-2917 |
| DOI: | 10.1094/PDIS-10-22-2463-RE |